Back
acm20v | 19040

Monitoring anti-CD20 immunotherapy

Keywords:
B cell depletion
anti-CD20 therapy
kesimpta
mabthera
ocrelizumab
ocrevus
ofatumumab
rituximab

Status

Material
Blood EDTA EDTA tube, purple (6)
Min. volume 2 mL
Stability
Stability
2 days / 18-25°C; 2 days / 2-8°C
Duration 1 day
Frequency 6 x per week (monday - saturday)
Method Flow cytometry with monoclonal antibodies

Price/Rate

Price
Price
CHF 81.00
Rate
Rate
81.00 TP

Consultants